On March 26, Catharina Svanborg bought 25,000 shares in the research company Hamlet Biopharma, where she is the principal owner and chair of the board. The shares were purchased at a price of SEK 6.98 per share, a transaction amounting to SEK 174,500. The transaction was carried out off-market. This is stated in Finansinspektionen's insider register.As of March 17, Svanborg owned 60.94 million shares, corresponding to 33.00 percent of the capital and 73.96 percent of the votes in Hamlet, according to the ownership service Holdings.